ArticlePatient preference and adherence2017

Evaluating the patient experience after implantation of a 0.4 mg sustained release dexamethasone intracanalicular insert (Dextenza™): results of a qualitative survey.

Joseph P Gira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.